HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pilot study of a new retinoid, Ro 12-7554, in psoriasis and in some congenital disorders of keratinization.

Abstract
Ro12-7554, a chlorinated derivative of etretinate, was evaluated in an open study. 16 patients, 13 suffering from severe psoriasis and 3 from congenital disorders of keratinization previously treated with etretinate, received Ro 12-7554 at a mean daily dosage of 12.3 mg/day. Ro 12-7554 was very similar to etretinate in terms of clinical efficacy and overall safety.
AuthorsF Ott, Y Bounameaux
JournalDermatologica (Dermatologica) Vol. 167 Issue 1 Pg. 52-3 ( 1983) ISSN: 0011-9075 [Print] Switzerland
PMID6226548 (Publication Type: Journal Article)
Chemical References
  • Tretinoin
  • Etretinate
  • Ro 12-7554
Topics
  • Adult
  • Dermatitis, Exfoliative (drug therapy)
  • Drug Evaluation
  • Etretinate (therapeutic use)
  • Female
  • Humans
  • Keratosis (drug therapy)
  • Male
  • Middle Aged
  • Psoriasis (drug therapy)
  • Skin Diseases, Vesiculobullous (drug therapy)
  • Tretinoin (adverse effects, analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: